Using extracorporeal membrane oxygenation in donations after cardiac death or brain death : A single-center experience and long-term outcome
© 2023 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterological Surgery..
Aims: The use of extended criteria donors is a routine practice that sometimes involves extracorporeal membrane oxygenation (ECMO) in donations after cardiac death or brain death.
Methods: We performed a retrospective study in a single center from January 2006 to December 2019. The study included 90 deceased donor liver transplants. The patients were divided into three groups: the donation after brain death (DBD) group (n = 58, 64.4%), the DBD with ECMO group (n = 11, 12.2%) and the donation after cardiac death (DCD) with ECMO group (n = 21, 23.3%).
Results: There were no significant differences between the DBD with ECMO group and the DBD group. When comparing the DCD with ECMO group and the DBD group, there were statistically significant differences for total warm ischemia time (p < 0.001), total cold ischemia time (p = 0.023), and split liver transplantation (p < 0.001), and there was significantly poor recovery in regard to total bilirubin level (p = 0.027) for the DCD with ECMO group by repeated measures ANOVA. The 5-year survival rates of the DBD, DBD with ECMO, and DCD with ECMO groups were 78.1%, 90.9%, and 75.6%, respectively. The survival rate was not significantly different when comparing the DBD group to either the DBD with ECMO group (p = 0.435) or the DCD with ECMO group (p = 0.310).
Conclusions: Using ECMO in donations after cardiac death or brain death is a good technology, and it contributed to 35.6% of the liver graft pool.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Annals of gastroenterological surgery - 8(2024), 2 vom: 01. März, Seite 312-320 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hsieh, Chia-En [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Donation after brain death |
|---|
| Anmerkungen: |
Date Revised 26.04.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1002/ags3.12749 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369452291 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369452291 | ||
| 003 | DE-627 | ||
| 005 | 20240426233848.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240308s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ags3.12749 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1388.xml |
| 035 | |a (DE-627)NLM369452291 | ||
| 035 | |a (NLM)38455485 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hsieh, Chia-En |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Using extracorporeal membrane oxygenation in donations after cardiac death or brain death |b A single-center experience and long-term outcome |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 26.04.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterological Surgery. | ||
| 520 | |a Aims: The use of extended criteria donors is a routine practice that sometimes involves extracorporeal membrane oxygenation (ECMO) in donations after cardiac death or brain death | ||
| 520 | |a Methods: We performed a retrospective study in a single center from January 2006 to December 2019. The study included 90 deceased donor liver transplants. The patients were divided into three groups: the donation after brain death (DBD) group (n = 58, 64.4%), the DBD with ECMO group (n = 11, 12.2%) and the donation after cardiac death (DCD) with ECMO group (n = 21, 23.3%) | ||
| 520 | |a Results: There were no significant differences between the DBD with ECMO group and the DBD group. When comparing the DCD with ECMO group and the DBD group, there were statistically significant differences for total warm ischemia time (p < 0.001), total cold ischemia time (p = 0.023), and split liver transplantation (p < 0.001), and there was significantly poor recovery in regard to total bilirubin level (p = 0.027) for the DCD with ECMO group by repeated measures ANOVA. The 5-year survival rates of the DBD, DBD with ECMO, and DCD with ECMO groups were 78.1%, 90.9%, and 75.6%, respectively. The survival rate was not significantly different when comparing the DBD group to either the DBD with ECMO group (p = 0.435) or the DCD with ECMO group (p = 0.310) | ||
| 520 | |a Conclusions: Using ECMO in donations after cardiac death or brain death is a good technology, and it contributed to 35.6% of the liver graft pool | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a donation after brain death | |
| 650 | 4 | |a donation after cardiac death | |
| 650 | 4 | |a extracorporeal membrane oxygenation | |
| 650 | 4 | |a liver transplantation | |
| 650 | 4 | |a long‐term outcome | |
| 700 | 1 | |a Hsu, Ya-Lan |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Yao-Li |e verfasserin |4 aut | |
| 700 | 1 | |a Liang, Hsin-Rou |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Kuo-Hua |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Wen-Yuan |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Hsiu-Man |e verfasserin |4 aut | |
| 700 | 1 | |a Hunang, Sin-Bao |e verfasserin |4 aut | |
| 700 | 1 | |a Hung, Yu-Ju |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of gastroenterological surgery |d 2017 |g 8(2024), 2 vom: 01. März, Seite 312-320 |w (DE-627)NLM285082434 |x 2475-0328 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2024 |g number:2 |g day:01 |g month:03 |g pages:312-320 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ags3.12749 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2024 |e 2 |b 01 |c 03 |h 312-320 | ||